Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034424

Chief Financial Officer sold 3,616 shares at $14.55 ($52,613)

From the SEC's structured data for this filing

Trades in this filing

Koppikar Utpal · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-18 Sale : show line 1 in the form −3,616 $14.55 $52,613 168,966 D
Open-market sales · 3,616 sh · avg $14.55 · $52,613
Loading xslF345X03/doc4.xml…